Vitamin B12 is a cobalt-containing, water-soluble vitamin belonging to the cobalamin family. It is found naturally in animal products and is unique among vitamins in requiring a specialized gastric protein called intrinsic factor (IF) for absorption in the terminal ileum. Because the body stores B12 primarily in the liver (for 2–5 years), deficiency develops slowly but can cause serious hematological and neurological consequences if untreated.

B12 functions as a cofactor for two critical enzymes in humans: methionine synthase, which converts homocysteine to methionine and is essential for DNA methylation and synthesis; and methylmalonyl-CoA mutase, which is required for proper fatty acid and amino acid metabolism. Through its role in methionine synthase, B12 is deeply intertwined with folate metabolism, and deficiency of either vitamin can impair cell division — particularly in rapidly dividing cells like red blood cell precursors and nerve-myelin-producing Schwann cells.

Oral supplementation at high doses (1,000–2,000 mcg/day) relies on passive absorption (approximately 1% of any dose) and is clinically effective even in patients with intrinsic factor deficiency or gastric atrophy, as demonstrated in multiple clinical trials. Sublingual tablets may enhance absorption marginally but evidence for superiority over oral tablets is not definitive. Intramuscular injections bypass the GI tract entirely and are the standard of care for patients with malabsorption syndromes. Nasal sprays provide an alternative mucosal route and are FDA-approved for maintenance therapy following normalization by injection.

• Vitamin B12 Deficiency
• Pernicious Anemia
• Peripheral Neuropathy
• Elevated Homocysteine (Hyperhomocysteinemia)
• Fatigue / Low Energy
• Cognitive Decline (B12-deficiency-related)
• Metformin-Induced B12 Depletion
• Vegans/Vegetarians at Risk of Deficiency

• Neural tube defects (B12 adequacy during early pregnancy reduces risk, complementary to folate)
• Megaloblastic anemia in at-risk populations (elderly, vegans, pernicious anemia patients)
• Progression of B12-deficiency neuropathy when corrected early
• Metformin-induced neuropathy and anemia with routine monitoring and supplementation

• Acneiform skin eruptions (rare; more commonly reported with high-dose cyanocobalamin injections; mechanism may involve B12-driven bacterial proliferation in sebaceous follicles)
• Injection-site pain, redness, or swelling (with IM administration)
• Rare hypersensitivity reactions to injectable preparations (anaphylaxis is extremely rare but documented for IM cyanocobalamin)
• Mild diarrhea or nausea reported occasionally at very high oral doses (generally self-limiting)
• Hypokalemia can occur during initial aggressive treatment of severe megaloblastic anemia as rapid blood cell production consumes potassium — monitoring is warranted in severe deficiency being treated intensively

• Recommended daily: Adults: RDA is 2.4 mcg/day from dietary sources; for supplementation to correct deficiency, standard oral doses are 1,000–2,000 mcg/day of cyanocobalamin or methylcobalamin. For maintenance in at-risk groups (vegans, elderly, metformin users), 250–500 mcg/day or 2,000 mcg/week are commonly used. Pregnancy: 2.6 mcg/day RDA; lactation: 2.8 mcg/day RDA. Intramuscular: typically 1,000 mcg/day for 7 days, then weekly for 4 weeks, then monthly for maintenance in absorption-impaired patients (protocol varies by clinical guidelines).
• Best time of day: No strong evidence for time-of-day preference; morning dosing is conventional and may support energy-related subjective benefits. Sublingual and oral forms can be taken at any time.
• With or without food: Can be taken with or without food. Taking with food does not meaningfully affect passive absorption at supplemental doses. For those relying on active absorption (low-dose dietary intake), food-matrix factors are more relevant.
• Time to effect: Hematological improvement (reticulocytosis) begins within 1–2 weeks; anemia typically resolves within 2–3 months; neurological symptoms begin to improve within 4–8 weeks but full neurological recovery may take 6–12 months and may be incomplete if damage was prolonged.
• How long to take it: For confirmed deficiency: continue indefinitely if the underlying cause (pernicious anemia, malabsorption, vegan diet, metformin use) is not reversible. For dietary deficiency in vegans: lifelong supplementation is necessary. For age-related reduced absorption: long-term supplementation recommended. No cycling is required; B12 does not require periodic breaks.